CD4 Association with Mortality in HIV Patients with Dyspnea in Dr Seotomo General Academic Hospital Surabaya
Downloads
Introduction: HIV AIDS patients who have a CD4 count < 200 cells/uL often complain of respiratory symptoms (Wallace, 1993). The complaint was shortness of breath (62%). Opportunistic infections (IO) in HIV patients are also brought on by a decreased CD4 count of 200 cells/uL (Peters, 2007). HIV/AIDS patients with CD4 < 200 cells/uL have a risk of death of 10.399 (Kusumaadhi, 2021). This study aims to determine the association between CD4 cell count with mortality in HIV patients with shortness of breath at Cendana, Dr. Soetomo General Academic Hospital Surabaya, during the period of January–December 2020.
Methods: This study used a cross-sectional retrospective design. The population in this study were patients diagnosed with HIV at Cendana, Dr. Soetomo General Academic Hospital, using a total sampling technique. The variables studied were the CD4 counts as the independent variable, and the mortality of HIV patients with dyspnea as the dependent variable. The sample in this study must meet the inclusion criteria, namely, the sample must have a history of CD4 counts in their medical record in the last 2 to 3 months while in Cendana, Dr. Soetomo General Academic Hospital. Secondary data from medical record data in Cendana, Dr. Soetomo General Academic Hospital, was used for the research from January to December 2020.
Results: A total of 128 HIV patients with dyspnea and a history of CD4 counts in the previous 3 to 4 months were included in the study: 79 (61.7%) males and 49 (38.3%) females. The most common age groups were 31–40 years (33.6%), 20–30 years (32.0%), 41–50 years (23.4%), and > 60 years (2.4%), with no patients under the age of 20. The distribution of the most opportunistic infections were: pneumocystis pneumonia (n = 62), tuberculosis (n = 49), and bacterial pneumonia (n = 17). Patients lived (n = 79) and died (n = 49) in total.
Conclusion: There was no significant association between CD4 count and mortality in HIV patients with dyspnea (p-value 0.084 > 0.05).
Amelia M, Hadisaputro S, Laksono B, et al. 2016. Faktor risiko yang berpengaruh terhadap kejadian HIV/AIDS pada laki-laki umur 25 - 44 tahun di Kota Dili, Timor Leste. Jurnal Epidemiologi Kesehat Komunitas 1(1):39-46.
CDC. 2020. HIV and MEN. Available at https://www.cdc.gov/hiv/group/gender/men/index.html. Accessed 4 January 2022.
Fei MW, Sant CA, Kim EJ, et al. 2009. Severity and outcomes of Pneumocystis pneumonia in patients newly diagnosed with HIV infection: an observational cohort study. Scandinavian Journal of Infectious Diseases 41(9):672-678. DOI: 10.1080/00365540903051633.
Gangcuangco LMA, Sawada I, Tsuchiya N, et al. 2017. Regional differences in the prevalence of major opportunistic infections among antiretroviral-naive human immunodeficiency virus patients in Japan, Northern Thailand, Northern Vietnam, and the Philippines. The American Journal of Tropical Medicine and Hygiene 97(1):49-56. DOI: 10.4269/ajtmh.16-0783.
Kusumaadhi ZM, Farhanah N, Sofro MAU. 2021. Risk factors for mortality among HIV/AIDS patients. Diponegoro International Medical Journal 2(1):20-19. https://doi.org/10.14710/dimj.v2i1.9667.
Pang W, Shang P, Li Q, et al. 2018. Prevalence of opportunistic infections and causes of death among hospitalized HIV-infected patients in Sichuan, China. The Tohoku Journal of Experimental Medicine 244(3):231-242. DOI: 10.1620/tjem.244.231.
Peters EJ, Essien OE, Immananagha KK, et al. 2007. CD4 count levels and pattern of respiratory complications in HIV seropositive patients in Calabar, Nigeria. Nigerian Journal of Physiological Sciences 22(1-2):93-97. DOI: 10.4314/njps.v22i1-2.54860.
Tiwari V, Shiddapur G, Sairam N, et al. 2020, Disease wise distribution of pulmonary involvement in HIV seropositive patients and its correlation with CD4 count. Indian Journal of Basic and Applied Medical Research 10(1):156-160. DOI: 10.36848/IJBAMR/2020/16215.55675.
Wallace JM, Rao AV, Grassroth J, et al. 1993. Respiratory illnesses in persons with human immunodeficiency virus infection. The pulmonary complication of HIV infection study group. Am Rev Respir Dis 148 (6 pt 1):1523 – 1529. DOI: 10.1164/ajrccm/148.6_Pt_1.1523.
Copyright (c) 2023 Moh. Hamzah Raka Pratama, Muhammad Vitanata Arfijanto, Maria Lucia Inge Lusida
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) Author
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).